Esra A Akbay

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Dna Damage Response

Small Cell Lung Cancer

Signaling Pathway

Top Venues

Nature communications

Science advances

The Journal of biological chemistry

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Buse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, Silvia Siteni, Mingrui Zhu, Kenian Chen, Matthew E Bender, Ilgen Mender, Victor Stastny, Benjamin J Drapkin, Prithvi Raj, John D Minna, Lin Xu, Jerry W Shay, Esra A Akbay
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer. Nature communications 15 (1) (2024)
Yujiro Naito, Syohei Koyama, Kentaro Masuhiro, Takashi Hirai, Takeshi Uenami, Takako Inoue, Akio Osa, Hirotomo Machiyama, Go Watanabe, Nicolas Sax, Jordan Villa, Yumi Kinugasa-Katayama, Satoshi Nojima, Moto Yaga, Yuki Hosono, Daisuke Okuzaki, Shingo Satoh, Takeshi Tsuda, Yoshimitsu Nakanishi, Yasuhiko Suga, Takayoshi Morita, Kiyoharu Fukushima, Masayuki Nishide, Takayuki Shiroyama, Kotaro Miyake, Kota Iwahori, Haruhiko Hirata, Izumi Nagatomo, Yukihiro Yano, Motohiro Tamiya, Toru Kumagai, Norihiko Takemoto, Hidenori Inohara, Sho Yamasaki, Kazuo Yamashita, Taiki Aoshi, Esra A Akbay, Naoki Hosen, Yasushi Shintani, Hyota Takamatsu, Masahide Mori, Yoshito Takeda, Atsushi Kumanogoh
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8 + T cell cytotoxicity and proliferation. Science advances 9 (20) (2023)
Yujiro Naito, Syohei Koyama, Kentaro Masuhiro, Takashi Hirai, Takeshi Uenami, Takako Inoue, Akio Osa, Hirotomo Machiyama, Go Watanabe, Nicolas Sax, Jordan Villa, Yumi Kinugasa-Katayama, Satoshi Nojima, Moto Yaga, Yuki Hosono, Daisuke Okuzaki, Shingo Satoh, Takeshi Tsuda, Yoshimitsu Nakanishi, Yasuhiko Suga, Takayoshi Morita, Kiyoharu Fukushima, Masayuki Nishide, Takayuki Shiroyama, Kotaro Miyake, Kota Iwahori, Haruhiko Hirata, Izumi Nagatomo, Yukihiro Yano, Motohiro Tamiya, Toru Kumagai, Norihiko Takemoto, Hidenori Inohara, Sho Yamasaki, Kazuo Yamashita, Taiki Aoshi, Esra A Akbay, Naoki Hosen, Yasushi Shintani, Hyota Takamatsu, Masahide Mori, Yoshito Takeda, Atsushi Kumanogoh
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8 + T cell cytotoxicity and proliferation. Science advances 9 (20) (2023)
Yujiro Naito, Syohei Koyama, Kentaro Masuhiro, Takashi Hirai, Takeshi Uenami, Takako Inoue, Akio Osa, Hirotomo Machiyama, Go Watanabe, Nicolas Sax, Jordan Villa, Yumi Kinugasa-Katayama, Satoshi Nojima, Moto Yaga, Yuki Hosono, Daisuke Okuzaki, Shingo Satoh, Takeshi Tsuda, Yoshimitsu Nakanishi, Yasuhiko Suga, Takayoshi Morita, Kiyoharu Fukushima, Masayuki Nishide, Takayuki Shiroyama, Kotaro Miyake, Kota Iwahori, Haruhiko Hirata, Izumi Nagatomo, Yukihiro Yano, Motohiro Tamiya, Toru Kumagai, Norihiko Takemoto, Hidenori Inohara, Sho Yamasaki, Kazuo Yamashita, Taiki Aoshi, Esra A Akbay, Naoki Hosen, Yasushi Shintani, Hyota Takamatsu, Masahide Mori, Yoshito Takeda, Atsushi Kumanogoh
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8 + T cell cytotoxicity and proliferation. Science advances 9 (20) (2023)
Ke Gong, Gao Guo, Nicole A Beckley, Xiaoyao Yang, Yue Zhang, David E Gerber, John D Minna, Sandeep Burma, Dawen Zhao, Esra A Akbay, Amyn A Habib
Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids. Nature communications 12 (1) (2021)
Ling Cai, Hongyu Liu, Fang Huang, Junya Fujimoto, Luc Girard, Jun Chen, Yongwen Li, Yu-An Zhang, Dhruba Deb, Victor Stastny, Karine Pozo, Christin S Kuo, Gaoxiang Jia, Chendong Yang, Wei Zou, Adeeb Alomar, Kenneth Huffman, Mahboubeh Papari-Zareei, Lin Yang, Benjamin Drapkin, Esra A Akbay, David S Shames, Ignacio I Wistuba, Tao Wang, Jane E Johnson, Guanghua Xiao, Ralph J DeBerardinis, John D Minna, Yang Xie, Adi F Gazdar
Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer. Communications biology 4 (1) (2021)
Yoshiko Takeuchi, Tokiyoshi Tanegashima, Eiichi Sato, Takuma Irie, Atsuo Sai, Kota Itahashi, Shogo Kumagai, Yasuko Tada, Yosuke Togashi, Syohei Koyama, Esra A Akbay, Takahiro Karasaki, Keisuke Kataoka, Soichiro Funaki, Yasushi Shintani, Izumi Nagatomo, Hiroshi Kida, Genichiro Ishii, Tomohiro Miyoshi, Keiju Aokage, Kazuhiko Kakimi, Seishi Ogawa, Meinoshin Okumura, Masatoshi Eto, Atsushi Kumanogoh, Masahiro Tsuboi, Hiroyoshi Nishikawa
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape. Science immunology 6 (65) (2021)
Salim Abdisalaam, Souparno Bhattacharya, Shibani Mukherjee, Debapriya Sinha, Kalayarasan Srinivasan, Mingrui Zhu, Esra A Akbay, Hesham A Sadek, Jerry W Shay, Aroumougame Asaithamby
Dysfunctional telomeres trigger cellular senescence mediated by cyclic GMP-AMP synthase. The Journal of biological chemistry 295 (32) (2020)
Juan J Miret, Paul Kirschmeier, Shohei Koyama, Mingrui Zhu, Yvonne Y Li, Yujiro Naito, Min Wu, Venkat S Malladi, Wei Huang, William Walker, Sangeetha Palakurthi, Glenn Dranoff, Peter S Hammerman, Chad V Pecot, Kwok-Kin Wong, Esra A Akbay
Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity. Journal for immunotherapy of cancer 7 (1) (2019)
Nadia B Hassounah, Venkat S Malladi, Yi Huang, Samuel S Freeman, Ellen M Beauchamp, Shohei Koyama, Nicholas Souders, Sunil Martin, Glenn Dranoff, Kwok-Kin Wong, Chandra S Pedamallu, Peter S Hammerman, Esra A Akbay
Identification and characterization of an alternative cancer-derived PD-L1 splice variant. Cancer immunology, immunotherapy : CII 68 (3) (2018)